SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2026
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
INTERNAL RULES OF THE SAFETY, ENVIRONMENT AND HEALTH COMMITTEE OF BRASKEM S.A. INTERNAL RULES OF THE SAFETY, ENVIRONMENT AND HEALTH COMMITTEE
OF BRASKEM S.A. 1. Objectives The Safety, Environment and Health Committee (“CSMS” or “Committee”) of Braskem
S.A. (“Braskem” or “Company”) is the statutory and permanent advisory body to Braskem's Board of Directors ("CA"
or "Board") in relation to the matters described in item 2 of these Internal Rules ("Rules"). In the exercise of their duties, the Committee
members shall act in strict compliance with the Company's mission and values and conduct their activities in accordance with corporate
governance best practices, the provisions of Law No. 6,404, dated December 15, 1976 (the "Brazilian Corporation Law"), as amended, the
regulations issued by the Brazilian Securities and Exchange Commission (“CVM”), the Shareholders' Agreement filed at the Company's
headquarters, where applicable, the Company's Bylaws ("Bylaws"), and this Rules. CSMS members shall comply with and ensure compliance
with this Rules, exercising their duties with loyalty and due care and maintaining the confidentiality of any information to which they
have access. 2. Attributions The CSMS shall: i. ii. iii. iv. v. vi. support the Board of Directors on monitoring the implementation of
the guidelines established in the Safety, Environment and Health Policies; evaluate, prior to the resolution by the Board of Directors,
the proposals from Braskem's Executive Management regarding updates to Safety, Environment and Health Policies; review Company information
concerning significant Safety, Environment and Health incidents with a high accident potential and/or significant reputational risk, with
special focus on lessons learned and management's response; propose to the Board the disclosure, in the Company's annual reports, of the
activities performed by the Committee whenever deemed appropriate; express its opinion on Safety, Environment and Health-related matters
whenever necessary for the Board's review and consideration; propose amendments to these Rules to the Board of Directors whenever deemed
necessary, in accordance with Braskem's Bylaws, other documents approved by the Board, and applicable legislation; vii. viii. ix. x. xi.
approve, annually, the calendar of ordinary meetings for the following year; annually approve the Basic Agenda for the ordinary meetings
of the following year, upon proposal by its Chairperson, covering matters within the Committee's scope and other activities required to
address assignments established by the Board; propose that management engage external consultants who may, in specific situations, contribute
to the Committee's activities, observing Braskem's established procurement procedures; evaluate the risks included in the Corporate Risk
Matrix and the respective mitigation plans related to matters within its scope of responsibility; and conduct an annual formal assessment
of its performance and the effectiveness of its meetings, processes, and governance practices, reporting the results, recommendations,
and improvement plans to the Board of Directors. 3. Operation of the CSMS 3.1. Composition and Term of Office The CSMS is composed of
at least three (3) and up to six (6) members appointed by the Board of Directors from among the effective and alternate members of the
Board of Directors and/or external members with relevant technical expertise and experience, observing the provisions of the Shareholders'
Agreements filed at the Company's headquarters. The Coordinator of the CSMS shall be appointed by the Board of Directors, subject to the
provisions of the Shareholders' Agreement filed at the Company's headquarters. The term of office of the CSMS members shall be two (2)
years and shall coincide with the term of office of the Board of Directors. The term of office of members of the Board of Directors, whether
effective or alternate, shall commence on the date of their appointment by the Board of Directors, while the term of office of external
members shall commence upon execution of the respective instrument of investiture as Committee member. The term of office of any member
shall terminate upon: (i) expiration of the term of office; (ii) resignation; or (iii) removal, at any time, by the Board of Directors.
If a member of the CSMS permanently ceases holding office as a member of the Board of Directors before the end of the respective term
of office, the Board of Directors shall appoint a replacement. The position of member of the CSMS is personal and non-delegable. 3.2.
Coordination The CSMS Coordinator will have the following duties: i. ii. iii. iv. v. vi. vii. viii. ix. x. propose changes to the CSMS,
when necessary, in the Basic Agenda and in the approved Annual Calendar, considering the recommendations of the other members of the CSMS;
ratify the agenda of the regular meetings of the CSMS, before its forwarding, by the Executive Secretary of the CA ("Secretary of Governance"
or "S-CA"), to the members of this Committee; call, conduct and coordinate the meetings of the CSMS; determine the need for extraordinary
meetings and propose the dates on which such meetings will be held and their respective agendas, without prejudice to the right of the
other members to request that such meetings be called; ensure that the call, agenda and support material for the meetings are forwarded
to the members of the CSMS, by the S-CA, within the period stipulated in these Rules; invite, whenever necessary or appropriate, members
of the Board, Braskem officers, other employees, external consultants and any other person holding information relevant to the purpose
of the meeting. Such invitations shall be made with the support of the S-CA; forward to the CA the analyses, opinions and reports prepared
within the scope of the CSMS and that must be submitted to the CA; forward to Management any proposal approved by the Committee regarding
the engagement of external consultants to support the Committee's activities, in accordance with the Company's procurement procedures;
ensure that the draft minutes of the meetings are forwarded to the members of the Committee, for consideration, within seven (7) business
days after the meeting; and to present to the Board of Directors any proposals for updating these Rules. 3.3. Meetings The CSMS develops
its activities primarily through working meetings and, for this purpose, meets ordinarily monthly, according to the approved Annual Calendar
and, extraordinarily, whenever the CSMS Coordinator or any of its members deems it necessary, in alignment with the CSMS Coordinator,
or when required by the circumstances. The ordinary meetings of the CSMS to consider matters of deliberation of the Board of Directors
shall preferably be held at least seven (7) days in advance of the dates scheduled for the Meetings of Braskem's Board of Directors ("RCA"
or "RCAs"), which may be in a shorter period of time, but always prior to the holding of the RCAs. The calls, agendas, as well as the
support materials for the meetings must be made available to the members of the Committee, by the S-CA, at least seven (7) calendar days
in advance of the date of the meeting, unless the majority of its members set a shorter deadline, but not less than forty-eight (48) hours,
in which case a duly instructed agenda must be made available. The meetings of the CSMS shall be held, preferably, at Braskem's main office,
and may be held remotely, by means of telephone conference, videoconference or by any other means of communication that allows the identification
of the member of the Committee and simultaneous communication with all other persons present at the meeting, and recording is not allowed.
In case of remote meetings, it will be the individual and exclusive responsibility of each member of the CSMS to adopt all necessary measures
to ensure the strict confidentiality of the meetings, and access by people not authorized by the CSMS Coordinator to any information handled
in the meeting is strictly prohibited. The means of communication to be used by the member of the Committee must be the one indicated
by the Company's Information Security Department. If it is impossible to use the indicated means, it will be up to the member of the Committee
to inform S CA in advance of the means of communication that will be used, so that the Information Security Department can carry out the
validation. Preferably, all members of the CSMS should be present at all meetings, whether in person or by means of telephone conference,
videoconference or any other means of communication. The minimum quorum required to hold a meeting must be more than half of the members.
The member of the CSMS who is unable to attend the meeting must inform the CSMS Coordinator in advance and indicate, if applicable, which
member will represent him, provided that such occasional representation shall not constitute a delegation, as set forth in item 3.1 of
these Rules. Whenever the Coordinator of the CSMS is unable to attend a meeting, he or she shall notify the other members in advance and
designate a substitute. The recommendations of the CSMS shall be recorded in minutes prepared by the S-CA and, after validation by the
members of the CSMS, shall be made available on Braskem's Governance Portal. The minutes shall be archived by the Corporate Governance
Department at the Company's offices. 3.4. Conflict of Interest If any of the members of the Committee is in a situation of conflict of
interest with a certain matter to be considered, they must promptly disclose the conflict to the Coordinator or to the S-CA, being prevented
from deliberating or otherwise intervening in the subject matter of the conflict. The impediment of the participation of the member will
be recorded in the minutes of the meeting. If the member fails to disclose such conflict of interest, any other Committee member who becomes
aware of it shall do so. Exceptionally, to protect its interests, the Company, by decision of the Legal Department, may restrict members
subject to a conflict of interest from accessing information and materials relating to the matter giving rise to the conflict, as well
as to the part of the meeting that deals with the subject. 3.5. General Provisions The S-CA shall be responsible for supporting the CSMS
in accordance with the duties set forth in the Internal Rules of the Board of Directors. All communications between the members of the
CSMS and external advisors, whenever applicable, shall be conducted under a confidentiality regime. In the event of any conflict between
these Rules and the Company's Bylaws, the latter shall prevail and these Rules shall be amended, to the extent necessary. These Internal
Regulations were approved at the ordinary meeting of Braskem's Board of Directors held on October 22, 2026, and will be made available
on the Company's website.






SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date: November 18, 2026
| |
BRASKEM S.A. |
| |
|
|
|
| |
|
|
|
| |
By: |
/s/ Carlos Augusto Machado Pereira de Almeida Brandão |
| |
|
|
| |
|
Name: |
Carlos Augusto Machado Pereira de Almeida Brandão |
| |
|
Title: |
Chief Financial Officer |
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This Notice to the Market may contain forward-looking statements. These statements are not historical facts, but rather are based on the
current view and estimates of the Company's management regarding future economic and other circumstances, industry conditions, financial
performance and results, including any potential or projected impact regarding the geological event in Alagoas and related legal procedures
on the Company's business, financial condition and operating results. The words “project,” “believe,” “estimate,”
“expect,” “plan”, “objective” and other similar expressions, when referring to the Company, are used
to identify forward-looking statements. Statements related to the possible outcome of legal and administrative proceedings, implementation
of operational and financing strategies and investment plans, guidance on future operations, the objective of expanding its efforts to
achieve the sustainable macro objectives disclosed by the Company, as well as factors or trends that affect the financial condition, liquidity
or operating results of the Company are examples of forward-looking statements. Such statements reflect the current views of the Company's
management and are subject to various risks and uncertainties, many of which are beyond the Company’s control. There is no guarantee
that the events, trends or expected results will actually occur. The statements are based on various assumptions and factors, including,
but not limited to, general economic and market conditions, industry conditions and operating factors, availability, development and financial
access to new technologies. Any change in these assumptions or factors, including the projected impact from the joint venture and its
development of technologies, from the geological event in Alagoas and related legal procedures and the unprecedented impact on businesses,
employees, service providers, shareholders, investors and other stakeholders of the Company could cause effective results to differ significantly
from current expectations. For a comprehensive description of the risks and other factors that could impact any forward-looking statements
in this document, especially the factors discussed in the sections, see the reports filed with the Brazilian Securities and Exchange Commission
(CVM). This Notice to the Market does not constitute any offer of securities for sale in Brazil. No securities may be offered or sold
in Brazil without being registered or exempted from registration, and any public offer of securities carried out in Brazil must be made
through a prospectus, which would be made available by Braskem and contain detailed information on Braskem and its management, as well
as its financial statements.